MELK Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of MELK Antibodies for investigating maternal embryonic leucine zipper kinase (MELK) protein. Monoclonal MELK Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MELK is a serine/threonine kinase that plays a critical role in cell proliferation and survival, particularly in cancer and stem cell biology. MELK's involvement in regulating cell cycle progression and apoptosis makes it a significant target for therapeutic interventions in various malignancies. Research focused on MELK can provide insights into tumorigenesis and potential pathways for targeted cancer therapies. Investigating MELK expression patterns helps researchers understand its role in different cellular processes and disease states. Advanced research techniques using MELK monoclonal antibodies enable precise detection and quantification in various experimental settings. Exploring MELK's interactions with other proteins reveals new pathways in cell signaling and regulation. Santa Cruz Biotechnology monoclonal MELK Antibodies support researchers worldwide in advancing our understanding of cancer biology and potential therapeutic strategies.